Clinical outcomes and toxicity in metastatic breast cancer patients treated with first or second-line cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy in Egypt
- DOI
- 10.11604/pamj.2026.53.121.49258
- Published
- 2026-03-11
- Container
- Pan African Medical Journal
- Publisher
- Pan African Medical Journal
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.11604/pamj.2026.53.121.49258,
title = {Clinical outcomes and toxicity in metastatic breast cancer patients treated with first or second-line cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy in Egypt},
author = {Hesham Mahmoud ElWakeel and Hagar Ibrahim Elghazawy and Nagy Samy Gobra and Asmaa Ali Kortoma},
year = {2026},
journal = {Pan African Medical Journal},
doi = {10.11604/pamj.2026.53.121.49258},
url = {https://doi.org/10.11604/pamj.2026.53.121.49258}
}RIS
TY - JOUR TI - Clinical outcomes and toxicity in metastatic breast cancer patients treated with first or second-line cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy in Egypt AU - Hesham Mahmoud ElWakeel AU - Hagar Ibrahim Elghazawy AU - Nagy Samy Gobra AU - Asmaa Ali Kortoma PY - 2026 JO - Pan African Medical Journal DO - 10.11604/pamj.2026.53.121.49258 UR - https://doi.org/10.11604/pamj.2026.53.121.49258 ER -
APA
ElWakeel, H. M., Elghazawy, H. I., Gobra, N. S., & Kortoma, A. A. (2026). Clinical outcomes and toxicity in metastatic breast cancer patients treated with first or second-line cyclin-dependent kinase (CDK) 4/6 inhibitors and endocrine therapy in Egypt. Pan African Medical Journal. https://doi.org/10.11604/pamj.2026.53.121.49258
Source records
- crossref · retrieved 2026-09-26T04:24:56.007Z